InterVenn Biosciences: Jason Myers, Carol Berry
InterVenn Biosciences has appointed Jason Myers and Carol Berry to its board of directors. Myers is CEO of Sequencing Health and was founder, CEO, and a board member at ArcherDx. Berry is senior VP and chief business officer at CellCarta. She was previously senior VP and general manager of the genomics services division at Asuragen.